AGM
"the Company announced that it will present in vitro and in vivo data on its new HIV integrase inhibitors (small molecules), a result of a recent lead optimization effort"
They working on "a new HIV integrase"????? What about results from excising product... such as MK8122????
As anticipated they (Merck and AMB) have no conclusive results on their supposedly lead HIV drug MK8122. Now they are going back to square one, but where will the funding come from??
NO wonder why the stock is at 0.30 and going lower and lower.
D